MOLECULAR CARCINOGENESIS
Author Guidelines
NIH Public Access Mandate
For those interested in the Wiley policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
Permission Request Form
Author Guidelines
Online Submission and Peer Review
Manuscript Submission
New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/MC. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.
Data Protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
RAPID REVIEW OF MANUSCRIPTS SUBMITTED PREVIOUSLY TO ANOTHER JOURNAL:
As stated in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” ( http://www.icmje.org ; Updated February 2006): “ If the manuscript has been submitted previously to another journal, it is helpful to include the previous editor’s and reviewers’ comments with the submitted manuscript, along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications and doing so may expedite the review process.”
For manuscripts previously submitted to other journals with impact factor more than 6, if authors include previous editor’s and reviewers’ comments along with their responses, Molecular Carcinogenesis will guarantee a rapid (within a week) in-house assessment, with three possible outcomes:
a) Acceptance or acceptance with minor changes (no additional external reviews needed);
b) Rejection;
c) Additional external review needed; in this case the authors will have the possibility of accepting the additional external review or withdrawing the manuscript.
Editorial office contact information:
MC Editorial Office
John Wiley & Sons
Email: mc@wiley.com
Manuscript Preparation
Main Text File
Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) format.
Your main document file should include:
• A short informative title containing the major key words. The title should not contain abbreviations
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract structured (intro/methods/results/conclusion) or unstructured
• Up to seven keywords;
• Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article.
• Main body: formatted as introduction, materials & methods, results, discussion, conclusion
• References;
• Tables (each table complete with title and footnotes);
• Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.
Molecular Carcinogenesis does not accept unsolicited Working Hypotheses or In Perspective Invited Reviews. Please do not submit any of these types of articles unless you have been specifically invited to do so.
Brief communications should not exceed 2,500 words (this does not include the abstract and title.) They can report preliminary data or ongoing work that does not warrant a full-length article. These communications must be complete manuscripts in which the traditional sections of the research paper may be combined. Include a complete reference list.
Research papers should contain the following sections: title page, abstract, introduction, materials and methods, results, discussion, acknowledgments (optional), references, tables, and figure legends. Use generic names of drugs and give manufacturer, city, and state or country of all trademarked equipment mentioned in the text. Research papers should not exceed 5,000 words within the main text. The figure limit is 7.
Working Hypothesis is a forum for presenting ideas for further experimentation. Each Working Hypothesis is the author's personal viewpoint, based either on the author's own work or on the published literature. Each should be no longer than 20 double-spaced pages and contain no more thn 20 references and two figures.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/10982744/homepage/forauthors.html
